Trial of Pimasertib in Hematological Malignancies

Clinical trial NCT00957580 · TERMINATED

Trial details

NCT number: NCT00957580
Sponsor: EMD Serono
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute Hematologic Neoplasms

Start date: 2009-09-30
Primary completion: 2012-12-31
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.